{
  "nct_id": "NCT06008730",
  "official_title": "Proton Beam Radiation Therapy in Patients with Resected N2 Non-Small Cell Lung Cancer",
  "brief_title": "Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer",
  "cancer_type_display": "A study evaluating proton beam radiation therapy for patients with resected N2 non-small cell lung cancer (NSCLC) who have received pre-operative systemic therapy.",
  "cancer_tags": [
    "Resectable Lung Non-Small Cell Carcinoma"
  ],
  "link_to_trial": "https://clinicaltrials.gov/study/NCT06008730",
  "phase": "Phase 2",
  "recruitment_status": "RECRUITING",
  "last_update_date": "2025-01-20",
  "enrollment": 20,
  "min_age": 18,
  "max_age": null,
  "sex": "ALL",
  "is_metastatic_allowed": false,
  "performance_status_scale": "ECOG",
  "performance_status_values": [
    0,
    1,
    2
  ],
  "min_prior_lines": null,
  "max_prior_lines": null,
  "prior_treatments_required": [
    "Complete surgical resection",
    "Pre-operative systemic therapy"
  ],
  "prior_treatments_excluded": [
    "Prior thoracic radiotherapy"
  ],
  "principal_investigator": "William Stokes",
  "site_name": "Emory University Hospital/Winship Cancer Institute",
  "contact_email": "william.stokes@emoryhealthcare.org",
  "contact_phone": "404-778-3473",
  "locations": [
    {
      "facility": "Emory University Hospital/Winship Cancer Institute",
      "status": "RECRUITING",
      "city": "Atlanta",
      "state": "Georgia",
      "zip": "30322",
      "country": "United States",
      "contacts": [
        {
          "name": "Tegan VandenBosch",
          "role": "CONTACT",
          "email": "tegan.honor.vandenbosch@emory.edu"
        },
        {
          "name": "William Stokes, MD",
          "role": "CONTACT"
        }
      ],
      "geoPoint": {
        "lat": 33.749,
        "lon": -84.38798
      }
    }
  ],
  "key_inclusion_summary": [
    "Must have undergone complete surgical resection (R0) after pre-operative systemic therapy.",
    "Pathology report must indicate tumor involvement of at least one mediastinal lymph node (pN2).",
    "ECOG performance status of 2 or less.",
    "Age 18 years or older."
  ],
  "key_exclusion_summary": [
    "Patients with stage IV (metastatic) disease.",
    "Incomplete surgical resection (R1 or R2).",
    "Prior thoracic radiotherapy.",
    "Tumors that have targetable alterations in EGFR or ALK.",
    "Significant cardiovascular disease within 3 months prior to study start."
  ]
}